rosiglitazone has been researched along with myristic acid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Flodgren, E; Kotarsky, K; Nilsson, NE; Olde, B; Owman, C | 1 |
Alves, PS; Bhattacharyya, M; Brand, GD; Cummins, CL; Ferreira, TAM; Grouleff, J; Krause, H; Leite, JRSA; Liu, J; Magomedova, L; Moreira, DC; Nogueira, PCN; Oliveira, AS; Poda, G; Queiroz, FJG; Romeiro, LAS; Sahin, C; Silveira, ER; Tiefenbach, J; Uehling, D | 1 |
Ayers, SD; Bernardes, A; Campos, JL; Cvoro, A; Palma, MS; Polikarpov, I; Puhl, AC; Reinach, PS; Saidemberg, DM; Silveira, RL; Skaf, MS; Webb, P; Yuan, J | 1 |
3 other study(ies) available for rosiglitazone and myristic acid
Article | Year |
---|---|
A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs.
Topics: Aequorin; Animals; Calcium; Cell Line; Dose-Response Relationship, Drug; Fatty Acids, Nonesterified; Genes, Reporter; Humans; Hypoglycemic Agents; Islets of Langerhans; Mice; Palmitic Acids; Receptors, Cell Surface; Rosiglitazone; Thiazoles; Thiazolidinediones; Time Factors; Tissue Distribution | 2003 |
Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases.
Topics: 3T3-L1 Cells; Anacardic Acids; Anacardium; Animals; Drug Design; Gene Expression; HEK293 Cells; Humans; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Nuts; PPAR alpha; PPAR delta; PPAR gamma; Protein Domains; Zebrafish | 2022 |
Mode of peroxisome proliferator-activated receptor γ activation by luteolin.
Topics: 3T3-L1 Cells; Animals; Base Sequence; DNA Primers; Gene Expression Regulation; Humans; Luteolin; Mice; Models, Molecular; Molecular Dynamics Simulation; Myristic Acid; PPAR gamma; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones | 2012 |